TrialCancer chemotherapy and pharmacology2013

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias.

Ivana Gojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.